Sleep Apnea and Gestational Diabetes

Obstructive Sleep Apnea and Gestational Diabetes : Incidence and Effects of Continuous Positive Airway Pressure Treatment on Glucose Metabolism

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02108197

Enrollment

Registered

2014-04-09

Start date

2014-04-30

Completion date

2016-12-31

Last updated

2018-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes, Sleep Apnea

Brief summary

The investigators hypothesize that pregnant women with gestational diabetes will have a high incidence of sleep apnea, and that the treatment of sleep apnea will lead to improved glucose control in these women.

Interventions

DEVICEContinuous positive airway pressure (S9, ResMed)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 50 Years

Healthy volunteers

Inclusion criteria

* gestational diabetes

Exclusion criteria

* pre-gestational diabetes

Design outcomes

Primary

Measure	Time frame	Description
glucose tolerance	two weeks	Measuring glucose, fructosamine and insulin levels following a mixed meal test at 0 and 2 weeks. Glucose and insulin will be measured at 0 minutes and every 30 minutes thereafter for 2 hours. Fructosamine will be measured at 0 minutes only.

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026